Mycenax Biotech (ROCO:4726) E10: NT$-2.10 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4726 Mycenax Biotech Inc ROCO:4726
43 GF Score
Price NT$24.50
GF Value NT$47.88
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mycenax Biotech E10?

Mycenax Biotech ROCO:4726 -4.67% 43 E10 is NT$-2.10 as of Dec. 2025. GuruFocus rates ROCO:4726 with a GF Score™ of 43/100 and a GF Value™ of NT$47.88 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mycenax Biotech's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$-0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$-2.10 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average E10 Growth Rate was -11.10% per year. During the past 5 years, the average E10 Growth Rate was -9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Mycenax Biotech was -8.50% per year. The lowest was -12.10% per year. And the median was -11.10% per year.

As of today (2026-07-18), Mycenax Biotech's current stock price is NT$24.50. Mycenax Biotech's E10 for the quarter that ended in Dec. 2025 was NT$-2.10. Mycenax Biotech's Shiller PE Ratio of today is .


Mycenax Biotech  (ROCO:4726) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mycenax Biotech E10 Related Terms


Mycenax Biotech E10 Historical Data

* Premium members only.

The historical data trend for Mycenax Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mycenax Biotech E10 Chart

Mycenax Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.39 -1.53 -1.79 -1.96 -2.10

Mycenax Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.96 -2.01 -2.03 -2.10 -2.10

ROCO:4726 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Mycenax Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycenax Biotech Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mycenax Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mycenax Biotech's Shiller PE Ratio falls into.


ROCO:4726
43GF Score
Mycenax Biotech Inc ROCO:4726
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mycenax Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mycenax Biotech's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.26/324.0540*324.0540
=-0.260

Current CPI (Dec. 2025) = 324.0540.

Mycenax Biotech Quarterly Data

per share eps CPI Adj_EPS
201603 -0.550 238.132 -0.748
201606 -0.480 241.018 -0.645
201609 -0.210 241.428 -0.282
201612 -0.210 241.432 -0.282
201703 -0.660 243.801 -0.877
201706 -0.210 244.955 -0.278
201709 0.200 246.819 0.263
201712 -1.045 246.524 -1.374
201803 -0.640 249.554 -0.831
201806 -0.510 251.989 -0.656
201809 -0.510 252.439 -0.655
201812 -0.850 251.233 -1.096
201903 -0.440 254.202 -0.561
201906 -0.240 256.143 -0.304
201909 -0.730 256.759 -0.921
201912 -0.340 256.974 -0.429
202003 -0.170 258.115 -0.213
202006 0.620 257.797 0.779
202009 -0.110 260.280 -0.137
202012 -0.100 260.474 -0.124
202103 0.850 264.877 1.040
202106 -0.450 271.696 -0.537
202109 -0.520 274.310 -0.614
202112 -0.380 278.802 -0.442
202203 0.120 287.504 0.135
202206 -0.760 296.311 -0.831
202209 -1.120 296.808 -1.223
202212 -0.980 296.797 -1.070
202303 -1.170 301.836 -1.256
202306 -0.820 305.109 -0.871
202309 -0.590 307.789 -0.621
202312 -0.740 306.746 -0.782
202403 -0.660 312.332 -0.685
202406 -0.490 314.175 -0.505
202409 -0.710 315.301 -0.730
202412 -0.410 315.605 -0.421
202503 -0.620 319.799 -0.628
202506 -0.660 322.561 -0.663
202509 -0.630 324.800 -0.629
202512 -0.260 324.054 -0.260

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$-2.10 mean?
Mycenax Biotech (ROCO:4726) has a E10 of NT$-2.10 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mycenax Biotech and its competitors.
Is Mycenax Biotech's E10 too high?
Mycenax Biotech's current E10 is NT$-2.10. Overall, Mycenax Biotech has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mycenax Biotech's E10 compare to VRTX and REGN?
Mycenax Biotech's E10 of NT$-2.10 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mycenax Biotech and its competitors. Mycenax Biotech's current E10 is NT$-2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mycenax Biotech stock overvalued right now?
Based on GuruFocus' analysis, Mycenax Biotech (ROCO:4726) is currently considered Possible Value Trap. The stock's GF Value™ is NT$47.88, compared to a current price of NT$24.50 — trading 48.8% below its estimated fair value. The current E10 is NT$-2.10. Mycenax Biotech's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Mycenax Biotech (ROCO:4726), the current E10 is NT$-2.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mycenax Biotech (ROCO:4726) Overvalued in 2026?

Based on GuruFocus' analysis, Mycenax Biotech stock appears to be undervalued. The current stock price of NT$24.50 is trading 48.8% below its estimated GF Value™ of NT$47.88. GuruFocus considers Mycenax Biotech to be Possible Value Trap.

Key valuation signals for ROCO:4726:

  • E10: NT$-2.10
  • GF Value™: NT$47.88 vs. price of NT$24.50 (48.8% below fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mycenax Biotech Business Description

Address No. 66, Shengyi 2nd Road, 7th Floor, Hsinchu Science Park, Hsinchu County, Zhubei, TWN, 302041
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards. The company's main operating region is located in Taiwan.
43GF Score

Get the complete analysis for ROCO:4726

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.50
Price
NT$47.88
GF Value